🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Our study is aimed to evaluate the efficacy and safety of HRS-2189 combined...
Status
Not Yet Recruiting
Location
Fudan Cancer Hospital
Start Date
2024-12-31
Trial ID
NCT06738745
To evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of 5041...
Status
Recruiting
Location
GenesisCare North Shore (Oncology)
Start Date
2025-06-15
Trial ID
NCT06830850
Treatments Being Tested
This is a phase 1, open-label, randomized study. The objective of this stud...
Status
Completed
Location
Nucleus Network Melbourne
Start Date
2024-09-25
Trial ID
NCT06559007
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, and safety of HRS-50...
Status
Recruiting
Location
The Second Affiliated Hospital of Harbin Medical University
Start Date
2024-09-25
Trial ID
NCT06568094
HS-20093 is a fully humanized IgG1 antibody-drug conjugate (ADC) which spec...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-08-19
Trial ID
NCT07115446
The study was designed to evaluate the pharmacokinetic effects of Rifampici...
Status
Completed
Location
The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital)
Start Date
2025-06-20
Trial ID
NCT07014488
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and prelimi...
Status
Recruiting
Location
Shanghai Jiaotong University School of Medicine, Renji Hospital
Start Date
2023-08-03
Trial ID
NCT05942001
Treatments Being Tested
The study aims to assess the safety and tolerability of SHR-4394 in combina...
Status
Recruiting
Location
West China Hospital of Sichuan University
Start Date
2026-04-08
Trial ID
NCT07407283
Treatments Being Tested